Medy-Tox Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Hyun-Ho Jung
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | 19.7% |
Management average tenure | no data |
Board average tenure | no data |
Recent management updates
Recent updates
Medy-Tox's (KOSDAQ:086900) Anemic Earnings Might Be Worse Than You Think
Mar 31Medy-Tox Inc.'s (KOSDAQ:086900) Prospects Need A Boost To Lift Shares
Feb 27Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield
Apr 02A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns
Feb 09Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend
Dec 18CEO
Hyun-Ho Jung (61 yo)
no data
Tenure
Mr. Hyun-Ho Jung serves as the Chief Executive Officer of Medy-Tox Inc. Mr. Hyun obtained Doctor of Science degree from Korea Advanced Institute of Science and Technology.